Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afaa0efd2bd3638a277550873b8e2b65 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
filingDate |
2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8085dcfa5e5c3ff03f5e875b6f5aefd |
publicationDate |
2007-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007281947-A1 |
titleOfInvention |
Diarylmethylpiperazines As Prophylactic Or Therapeutic Agents For Viral Myocarditis |
abstract |
To provide a prophylactic or therapeutic agent for viral myocarditis and viral myocarditis-related viral diseases by preventing or treating the occurrence of cell damage in various organs regardless of the type of virus. A prophylactic or therapeutic agent for viral myocarditis and via myocarditis-related via diseases is provided that comprises as an active ingredient 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acid, amide derivative, individual optical isomer or pharmaceutically acceptable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8314083-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9180090-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8263581-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011003781-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8513259-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9161902-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119771-B2 |
priorityDate |
2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |